Skip to content
Screener

Astrana Health ASTH Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$972.5MMiss by $9.7M
EPS$0.40Beat by $0.06
Revenue estimate$982.2M
EPS estimate$0.34
“Our second quarter results reflect the strength of Astrana's physician-centric, AI-native healthcare operating system and the disciplined execution of our team. We continue to see accelerating demand from both providers and payers for our platform, driving strong growth, record-high adjusted diluted EPS, and robust free cash flow generation. Our performance gives us the confidence to raise our adjusted EBITDA guidance for 2026 even as we reinvest a substantial portion of our first-half outperformance into attractive growth opportunities that we believe will further strengthen our earnings power over time.”
Brandon Sim

Next report

Nov 5, 2026 (In 3 days)
Revenue estimate$1.0B
EPS estimate$0.46

Financials

Q2 2026

Income statement

See full
Revenue$972.5M+48.5%
Gross profit$104.0M+33.4%
Operating income$34.3M+68.7%
Net income$19.7M+109%
EPS (diluted)$0.40+111%

Balance sheet

See full
Cash & equivalents$400.8M+18.0%
Total debt$979.4M+119%
Total equity$830.2M+8.5%
Total assets$2.3B+58.2%

Cash flow

See full
Operating cash flow$32.7M-64.0%
CapEx$3.9M+173%
Free cash flow$28.9M-67.7%

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$1.82B+23.7%
Enterprise value$2.4B+14.4%
P/E44.8×—
P/S0.5×0.0×

Profitability

See full
Gross margin10.5%-0.8pp
Operating margin2.6%-0.3pp
Net margin1.1%—
FCF margin2.6%—

Returns & leverage

See full
Return on equity5.1%—
Debt / equity1.2×+0.6×
Current ratio1.2×-0.4×

Segments

By product

See full
Health Care Patient Service$23.0M+28.5%
Health Care Other$21.8M+41.6%
Management Service$13.2M+413%

FAQ

When did Astrana Health report Q2 2026 earnings?
Astrana Health (ASTH) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Astrana Health's Q2 2026 revenue and EPS?
Astrana Health reported revenue of $972.5M and eps of $0.40 for Q2 2026.
Did Astrana Health beat estimates in Q2 2026?
Revenue missed the consensus estimate of $982.2M by $9.7M. EPS beat the consensus estimate of $0.34 by $0.06.
How did Astrana Health's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 48.5% from $654.8M a year earlier and eps grew 110.5% from $0.19.
Where can I find Astrana Health's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-092003) and the 10-Q periodic report (0001193125-26-342631) directly on SEC EDGAR. The filing index links above go to sec.gov.